The Chemopreventive Role of Ursodeoxycholic Acid in Colon Cancer Model : Suppressive Effects on Enhanced Group II Phospholipase A2 Expression

熊去氧胆酸在结肠癌模型中的化学预防作用:对增强的 II 族磷脂酶 A2 表达的抑制作用

基本信息

  • 批准号:
    08670555
  • 负责人:
  • 金额:
    $ 1.41万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1996
  • 资助国家:
    日本
  • 起止时间:
    1996 至 1997
  • 项目状态:
    已结题

项目摘要

We here report the possible suppressive mechanisms of ursodeoxycholic acid (UDCA) on azoxymethane (AOM) -induced colon cancer model rat. In relation to arachidonate metabolism, we focused on the regulation of group II phospholipase A_2 (PLA_2) expression after AOM treatment. (Materials and Methods) (1) F344 rats were fed standard diet containing 0.4% or 1% of UDCA.Total aberrant crypt counts along with enzymatic activity, protein mass, and steady-state mRAN levels of group II PLA_2 were determined at 2,4,6,12 weeks after exposure of AOM.(2) HepG2 cells incubated with 50microM UDCA were stimulated by IL-6 and TNF-alpha. The expression levels of group II PLA_2 protein and mRNA were determined. (Results) (1) Twelve weeks after AOM exposure, the total number of aberrant crypt foci in 0.4% UDCA-diet fed rats and 1% UDCA-diet fed rats was significantly decreased compared to the untreated animals. The mucosal concentration of PGE_2 and 6-keto-PGF1alpha were significantly lower in the UDCA-trested rats than untreated rats. In correlation with lowering, the enhanced activity, protien mass, and mRNA levels of group II PLA_2 were significantly attenuated in the UDCA-treated animals. (2) Pro-inflammatory cytokine-induced group II PLA_2 expression in HepG2 cells were suppressed by incubation with UDCA.(Conclusions) UDCA administration decreased the total number of aberrant crypt foci in AOM-treated colonic tissue in which the enhanced group II PLA_2 expression was significantly attenuated. This chemopreventive role of UDCA in colon carcinogenesis may lie in its modulation of the arachidonate metabolism in colonic mucosa. In addition, it is supposed that this suppressive effect may be caused from direct action of UDCA to inflammed cells.
本文报道熊去氧胆酸(UDCA)对氧化偶氮甲烷(AOM)诱发大鼠结肠癌的抑制作用及其可能的机制。在花生四烯酸代谢方面,我们重点研究了AOM处理后Ⅱ型磷脂酶A_2(PLA_2)表达的调节。(材料与方法)(1)给F344大鼠喂饲含0.4%或1% UDCA的标准饲料,于AOM染毒后2、4、6、12周测定Ⅱ组PLA_2的异常隐窝总数沿着、酶活性、蛋白质质量和稳态mRAN水平。(2)用IL-6和TNF-α刺激与50 μ M UDCA孵育的HepG 2细胞。测定Ⅱ型PLA_2蛋白和mRNA的表达水平。(结果)(1)AOM暴露12周后,0.4%UDCA饲料喂养组和1%UDCA饲料喂养组大鼠的异常隐窝病灶总数明显低于未处理组。UDCA组大鼠胃粘膜PGE_2和6-keto-PGF_(1 α)含量明显低于对照组。UDCA处理组Ⅱ型PLA_2的活性、蛋白质量和mRNA水平均显著降低。(2)UDCA可抑制HepG 2细胞中促炎性丝氨酸诱导的Ⅱ型PLA_2表达。(结论)UDCA可减少AOM处理的结肠组织中异常隐窝病灶的总数,并可显著降低II组PLA_2的表达。UDCA在结肠癌发生中的化学预防作用可能在于其调节结肠粘膜中的花生四烯酸代谢。此外,推测这种抑制作用可能是由UDCA对炎症细胞的直接作用引起的。

项目成果

期刊论文数量(21)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Matsuzaki Y, et al.: "The usefulness of proton irradiation for hepatocellular carcinoma : present status and future prospects" Progress in Hepatology. 3. 117-132 (1997)
Matsuzaki Y 等人:“质子照射对肝细胞癌的有用性:现状和未来前景”肝病学进展。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Chiba T,: "The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma." Am J Gastroenterol,. 91. 1195-1203 (1996)
Chiba T,:“既往乙型肝炎病毒感染和大量吸烟在丙型肝炎病毒相关肝细胞癌中的作用。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shoda J,: "The inhibitory efects of Dai-Chai-Hu-Tang(Daisaiko-to) extract on supersaturated bile formation in choresterol gallstone disease" Ame J Gastrometerol,. 91. 828-830 (1996)
Shoda J,:“大柴胡汤(Daisaiko-to)提取物对乔甾醇胆石病中过饱和胆汁形成的抑制作用”Ame J Gastrometerol,。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shoda J,Matsuzaki Y,et al.: "The inhibitory effects of Dai-Chai-Hu-Tang (Dai-Saiko-To) extract supersaturated bile formation in cholesterol gallstone disease." Am J Gastroenterol. 191 (4). 828-830 (1996)
Shoda J、Matsuzaki Y 等人:“大柴胡汤 (Dai-Saiko-To) 提取物对胆固醇胆结石疾病过饱和胆汁形成的抑制作用。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Matsuzaki, Y. Bouscarel, B. et al.: "Effects of cholestasis on regulation of cAMP synthesis by glucagon and bile acids in isolated hepatocytes." Am.J.Physiol.273. G164-G174 (1997)
Matsuzaki, Y. Bouscarel, B. 等人:“胆汁淤积对分离肝细胞中胰高血糖素和胆汁酸调节 cAMP 合成的影响”。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MATSUZAKI Yasushi其他文献

緩和医療の現状と今後の展望
姑息治疗的现状及未来展望
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    HIRAYAMA Aki;TOMITA Tsutomu;YOKOTA Hiroo;KASAMAKI Yuji;MATSUZAKI Yasushi;AOYAGI Kazumasa;蓮尾英明
  • 通讯作者:
    蓮尾英明

MATSUZAKI Yasushi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MATSUZAKI Yasushi', 18)}}的其他基金

Invasive metabolic markers for evaluation of host factor on the pathological progress of hepatitis C patients
侵袭性代谢标志物评价宿主因素对丙型肝炎患者病理进展的影响
  • 批准号:
    23590992
  • 财政年份:
    2011
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a novel therapy targeting new intracellular receptors for the treatment of malignant melanoma
开发针对新细胞内受体的新疗法用于治疗恶性黑色素瘤
  • 批准号:
    21791057
  • 财政年份:
    2009
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Development of a novel sonodynamic therapy for skin cancers
开发一种新型皮肤癌声动力疗法
  • 批准号:
    19790769
  • 财政年份:
    2007
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Chemoprevention of hepatocellular carcinoma by dehydroepiandrosterone and its derivatives
脱氢表雄酮及其衍生物对肝细胞癌的化学预防
  • 批准号:
    15390225
  • 财政年份:
    2003
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Suppressive effect of ursodeoxycholic acid on type IIA phospholipase A2 expression in HepG2 cells.
熊去氧胆酸对 HepG2 细胞中 IIA 型磷脂酶 A2 表达的抑制作用。
  • 批准号:
    12670457
  • 财政年份:
    2000
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of proton beam therapy for hepatocellular carcinoma
肝细胞癌质子束治疗的建立
  • 批准号:
    06670518
  • 财政年份:
    1994
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Elucidation of pathogenesis and UDCA effect mechanisms in primary biliary cirrhosis
阐明原发性胆汁性肝硬化的发病机制和UDCA作用机制
  • 批准号:
    04670407
  • 财政年份:
    1992
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Evaluating the effectiveness and sustainability of integrating helminth control with seasonal malaria chemoprevention in West African children
评估西非儿童蠕虫控制与季节性疟疾化学预防相结合的有效性和可持续性
  • 批准号:
    MR/X023133/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Fellowship
Applying Population Management Best Practices to Preventive Genomic Medicine
将人口管理最佳实践应用于预防性基因组医学
  • 批准号:
    10674202
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
Mechanisms of Serrated Colon Tumor Suppression
锯齿状结肠肿瘤抑制机制
  • 批准号:
    10681608
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
Pilot Project 1
试点项目1
  • 批准号:
    10762162
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
Epigallocatechin gallate for prevention of lethal cirrhosis complications
表没食子儿茶素没食子酸酯用于预防致命性肝硬化并发症
  • 批准号:
    10713745
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
Clinical breast cancer risk prediction models for women with a high-risk benign breast diagnosis
高风险良性乳腺诊断女性的临床乳腺癌风险预测模型
  • 批准号:
    10719777
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
Stress adaptation in obesity-associated pancreatic cancer
肥胖相关胰腺癌的压力适应
  • 批准号:
    10581170
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
Targeting cancer stem-like cells and inflammation for colon cancer chemoprevention
针对癌症干细胞样细胞和炎症进行结肠癌化学预防
  • 批准号:
    10650910
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
Examining the mechanisms and optimization of malaria chemoprevention strategies to improve birth outcomes in Africa
检查疟疾化学预防策略的机制和优化,以改善非洲的出生结果
  • 批准号:
    10642646
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer
以前列腺癌为模型的强化降胆固醇干预和抗肿瘤免疫
  • 批准号:
    10802975
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了